Ikarian Capital’s Clene CLNN Stock Holding History

Ikarian Capital’s Portfolio CLNN Stock Details CLNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,870	Closed	-$496K	–	92
2022 Q3	$496K	Buy	+8,870	New	+$588K	0.1%	84

Other funds holding CLNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ikarian Capital's CLNN Position: Q3 2022 in Review

Ikarian Capital sold out of Clene (CLNN) in Q3 2022, closing a stake of 3,500 shares — an estimated $232K sold.

Ikarian Capital first reported a position in CLNN in Q1 2021 and held it in 6 quarters. The position peaked at $3.34M in Q3 2021. 38 funds tracked by Wall St. Rank hold CLNN as of Q3 2022.

Ikarian Capital reported no remaining Clene position as of Q3 2022 after selling out during the quarter.
Ikarian Capital sold 3,500 Clene shares in Q3 2022, an estimated $232K.
Ikarian Capital first reported a position in Clene in Q1 2021 and held it in 6 quarters.
Ikarian Capital's Clene position peaked at $3.34M in Q3 2021.
38 funds tracked by Wall St. Rank held Clene as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.